[{"Assets_0_Q3_USD":219992000.0,"CommonStockSharesOutstanding_0_Q3_shares":60664857.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-110945000.0,"NetIncomeLoss_1_Q3_USD":-48083000.0,"NetIncomeLoss_3_Q3_USD":-120197000.0,"StockholdersEquity_0_Q3_USD":171078000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q3_USD":239000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_3_Q3_USD":30130000.0,"Ticker":"KPTI","CIK":"1503802","name":"KARYOPHARM THERAPEUTICS INC.","OfficialName":"Karyopharm Therapeutics Inc. Common Stock","form":"10-Q","period":"20180930","fy":"2018.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"566245834.0","Country":"United States","Sector":"Miscellaneous","Industry":"Diversified Commercial Services","Market":"NASDAQ","SP500":"nan","filed":"20181108"}]